BE852363A - Analogues de prostaglandines - Google Patents

Analogues de prostaglandines

Info

Publication number
BE852363A
BE852363A BE175715A BE175715A BE852363A BE 852363 A BE852363 A BE 852363A BE 175715 A BE175715 A BE 175715A BE 175715 A BE175715 A BE 175715A BE 852363 A BE852363 A BE 852363A
Authority
BE
Belgium
Prior art keywords
prostaglandin analogues
prostaglandin
analogues
Prior art date
Application number
BE175715A
Other languages
English (en)
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of BE852363A publication Critical patent/BE852363A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE175715A 1976-03-12 1977-03-10 Analogues de prostaglandines BE852363A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB10118/76A GB1580201A (en) 1976-03-12 1976-03-12 Prostaglandin analogues

Publications (1)

Publication Number Publication Date
BE852363A true BE852363A (fr) 1977-09-12

Family

ID=9961833

Family Applications (1)

Application Number Title Priority Date Filing Date
BE175715A BE852363A (fr) 1976-03-12 1977-03-10 Analogues de prostaglandines

Country Status (4)

Country Link
JP (1) JPS6023111B2 (fr)
BE (1) BE852363A (fr)
GB (1) GB1580201A (fr)
ZA (1) ZA771462B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813541A (ja) 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物

Also Published As

Publication number Publication date
JPS59144754A (ja) 1984-08-18
JPS6023111B2 (ja) 1985-06-05
GB1580201A (en) 1980-11-26
ZA771462B (en) 1978-02-22

Similar Documents

Publication Publication Date Title
FR2337712A1 (fr) Analogues nouveaux de prostaglandines
BE868767A (fr) Analogues de prostacycline
BE868202A (fr) Analogues de prostacycline
IT8619809A0 (it) Analoghi di prostaglandine.
BE857761A (fr) Analogues de prostaglandines et leur preparation
DD130548A5 (de) Foerderer
FR2337714A1 (fr) Nouveaux analogues de prostaglandines
BE854463A (fr) Ethers de prostaglandines
BE850202A (fr) Analogues de prostaglandines
IT7827956A0 (it) Analoghi di prostaglandina i2.
BE857621A (fr) Analogues de cephalosporines
BE854271A (fr) Analogues de prostaglandines et leur preparation
IT1099181B (it) Analoghi prostaciclinici
BE824196A (fr) Prostaglandines
BE851357A (fr) Analogues des prostaglandines
FR2299022A1 (fr) Antagonistes de prostaglandines
ZA7717B (en) Prostaglandin analogues
FR2320084A1 (fr) Analogues de prostaglandines
PT64737A (fr) Prostaglandin analogues
BE852363A (fr) Analogues de prostaglandines
IT7824459A0 (it) Analoghi di prostaglandine.
FR2289182A1 (fr) Analogues de prostaglandines
BE853801A (fr) Analogues de prostaglandines et leur preparation
BE856739A (fr) Composes analogues aux prostaglandines
FR2361362B1 (fr) Analogues des prostaglandines

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ONO PHARMACEUTICAL CO. LTD

Effective date: 19890331